Psychological wellness, yoga and quality of life in patients affected by schizophrenia spectrum disorders: A pilot study by Caponnetto, Pasquale et al.
[page 22]                                                                [Mental Illness 2019; 11:8003]
Psychological wellness, yogaand quality of life in patientsaffected by schizophrenia spec-trum disorders: A pilot study
Pasquale Caponnetto,1-3
Roberta Auditore,1 Marilena Maglia,1,2
Stefano Pipitone,4,5 Lucio Inguscio6
1CTA-Villa Chiara Psychiatric
Rehabilitation Clinic and Research,
Mascalucia, Italy; 2Department of
Clinical and Experimental Biomedicine,
University of Catania, Italy; 3Institute
for Social Marketing, University of
Stirling, UK; 4Vidya Vahini Trust,
Uttarkashi, Himalayas, India; 
5Yoga Vidya, Siracusa, Italy;
6Department of Psychology, La Sapienza
University, Rome, Italy
Abstract
Schizophrenia is a serious psychiatric
disorder characterized by positive symp-
toms, negative symptoms and neurocogni-
tive deficits. The aim of this study was to
estimate relationships between wellness,
yoga and quality of life in patients affected
by schizophrenia spectrum disorders.
Participants were 30 patients with a diagno-
sis of schizophrenia in care at the
Rehabilitative Psychiatry and Research
Villa Chiara Clinic in Mascalucia (Catania,
Italy), after that randomly assigned to two
groups. The first group followed the exper-
imental treatment with sets of yoga exercis-
es conducted by a yoga trainer and a psychi-
atrist or a clinical psychologist expert in
yoga, while a second control group was
treated with usual care. The results revealed
a significant difference, before and after
treatment, between the experimental group
and the control group in quality of life.
Introduction
Yoga means union through discipline,
as it harmonizes the body the mind and the
emotions. Thus, the practice guides the
brain, and body to work in harmony.1
Schizophrenia is a severe psychiatric
disorder, affects approximately 24 million
people worldwide.2 This disorder is charac-
terized by i) positive symptoms such as hal-
lucinations and delusions, ii) negative
symptoms including affective flattening,
alogia and avolition and iii) neurocognitive
deficits including perception, memory and
attention.3 Negative and cognitive symp-
toms, emerging in the pre-psychotic stage,
appear to be related,4 and cognitive symp-
toms are significantly associated with poor-
er functional outcome.5,6
Several clinical and experimental arti-
cles showed that yoga reduces stress.7
Specifying the paths through which yoga
may reduce stress will increase the likeli-
hood that it will be recommended and
implemented as a complement to psycho-
logical and pharmacologic therapy for
stress-related conditions.8
Schizophrenia spectrum disorders have
substantial impact on quality of life, well-
being and social and occupational func-
tion9,10 and thus creates a considerable
socio-ecomic burden.11,12
The study conducted by Visceglia and
Lewis (2010), showed that yoga adjunct to
conventional psychiatric treatment, reduced
psychopathology, distress and improved
aspects of quality of life in inpatients with
schizophrenia spectrum disorders.
Specifically the yoga group obtained signif-
icant improvements in positive and negative
symptoms of schizophrenia symptoms com-
pared to control group, including PANSS
scores on positive syndrome (t=-2.64,
P=0.02), negative syndrome (t=-3.04,
P<0.01), general psychopathology (t=-3.74,
P<0.00), activation (t=-2.29, P<0.04), para-
noia (t=-2.89, P<0.01), and depression sub-
scales (t=2.62, P<0.02). PANSS total scores
also decreased for the yoga group (t=-4.54,
P<0.00). Yoga group had improved per-
ceived quality of life in physical (t=2.38,
P<0.04) and psychological domains
(t=2.88, P<0.01).13
With this in mind we designed a small
randomized pilot/feasibility study to assess
relationships between wellness, yoga and
quality of life in patients affected by schiz-
ophrenia spectrum disorders.
Materials and Methods
Participants
For the present study, a sample of 30
patients in rehabilitation at “Villa Chiara”
Psychiatric Rehabilitation and Research,
Mascalucia (Catania, Italy), aged between
18 and 65 years with a diagnosis of schizo-
phrenia in line with the DSM-V criteria
(American Psychiatric Association, 2013),
was selected. After informed consent has
been obtained, the patients were tested in
the areas of specific interest to the goals of
the research work and were then randomly
assigned to one of the treatment conditions,
15 experimental treatment (yoga + usual
care) or 15 control group (usual care), on
the basis of the following inclusion/exclu-
sion criteria. The participants were assigned
to two groups with a 1:1 ratio.
As main criteria for inclusion, in addi-
tion to the first one, represented by the diag-
nosis of schizophrenia according to DSM-V
criteria, the following were considered: i)
Pharmacological treatment unchanged for
at least six months and responsivity to the
same in clinical stable conditions; ii)
Willingness to take part in the study with
constancy for 90 minutes, one time a week
for three months.
Patients presenting the following were
excluded: i) Psychopathological, neurologi-
cal comorbidity and epilepsy; ii) QI<70
Objectives
The primary goal was represented by
improving the wellness perception (quality
of life, stress self-perception, blood cortisol
levels and blood Dehydroepiandrosterone
(DHEA) level.
Secondary goals are: i) Improvement of
the general psychopathological function-
ing;14 ii) Improvement of the adaptive func-
tioning.15,16
Assessment
During the assessment phase, the data
collection related to the personal, family
and pathologic history of each patient was
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initially gathered. At baseline (T0) the fol-
lowing profiles were evaluated: blood corti-
sol and Dehydroepiandrosterone (DHEA)
level, quality of life by the EuroQol VAS,17
stress perception by Perceived Stress Scale
(PSS),18 Psychopathological by PANSS,14
as well as adaptive functioning through the
Mini-ICF-APP.15,16 The yoga training
allows sets of exercises to be created on the
basis of limits and resources observed in
assessment. The results obtained after 12
weeks of yoga were then compared with
those obtained at baseline in order to evalu-
ate the effect of the experimental treatment
and monitor effects obtained among partic-
ipants.
Materials
Stress was assessed by the Perceived
Stress Scale (PSS). The PSS is the most
widely used psychological instrument for
measuring the perception of stress.17 The
PSS was designed to determine “the degree
to which situations in one’s life are
appraised as stressful”.17 On the basis of the
transactional model of stress and coping,
the PSS was designed to measure the degree
to which an individual believes his/her life
has been unpredictable, uncontrollable and
overloaded during the past month.17
Quality of life was assessed by EQ-5D,
EQ Visual Analogue scale (EQ VAS)
(EuroQol).18 The EQ VAS records the
respondent’s self-rated health on a 20 cm
vertical, visual analogue scale with end
points labeled the best health you can imag-
ine and the worst health you can imagine.
The EQ VAS scores are anchored on 100 =
the best health you can imagine and 0 = the
worst health you can imagine. It is a stan-
dardized instrument for use as a generic
measure of health outcome, quality of life. 
The Positive and Negative syndrome
scale (PANSS)14 has 30-item, each item on
the PANSS is accompanied by a complete
definition as well as detailed anchoring cri-
teria for seven rating points, which repre-
sent increasing levels of psychopathology:
1 = absent, 2 = minimal, 3 = mild, 4 = mod-
erate, 5 = moderate- severe, 6 = severe, and
7 = extreme.
The PANSS ratings is based on all
information pertaining to a specified period.
All ratings accrue from a 30 to 40-minute
semi-formalized psychiatric interview that
permits direct observation of affective,
motor, cognitive, perceptual, attentional,
integrative, and interactive functions. 
The PANSS is scored by summation of
ratings across items, such that the potential
ranges are 7-49 for the Positive and
Negative Scales and 16-112 for the General
Psychopathology Scale.
The Mini-ICFAPP is an instrument cre-
ated to assess limits and resources in people
with serious mental disorders;15 these are
rated in terms of competence throughout
thirteen aspects: namely adherence to regu-
lations, planning and structuring of tasks,
flexibility, competency, endurance,
assertiveness, contact with others, group
integration, intimate relationships, non-
work activities, self-care, mobility and
competence to judge and decide. This
dimension is evaluated on a five-point
Likert scale (0 = no impairment; 5 = total
disability). Assessment is based on informa-
tion provided by patients, care givers, clini-
cal records, as well as direct subjects’ clini-
cal observation. 
Procedures
Patients involved in our research work
were assigned to two separated groups that
followed for three months a yoga program
in addition to standard rehabilitation (SRT)
or SRT alone. The participants were ran-
domly assigned to each group, and the
blood cortisol, and Dehydroepiandrosterone
(DHEA) levels, the EuroQol VAS, PSS,
PANSS and Mini-ICF-APP were evaluated
and compared at baseline (T0) and after
three months (T1). 
After checking that all the necessary
criteria for inclusion (or exclusion) had
been met, patients were first admitted to the
study and subsequently assigned to the
experimental group or to the control group,
thanks to the computer-generated random
number tables, and therefore any statistical-
ly significant differences between the two
groups at baseline were excluded.
The experimental condition (yoga +
usual care) consisted of one weekly ses-
sions of one and half hour for a total dura-
tion of 12 weeks. The training was mod-
elled on the participants, considering the
baseline assessment. 
Yoga is a series of postures where the
body is being stabilized through breathing
pattern, with a positive or healthy attitude.
Nowadays, there are many methods of
teaching Yoga. 
The method of teaching adopted during
the study is named as Yoga Vidya and it is
founded by Swami Ananda Saraswati. Yoga
teachers were provided by the association
Yoga Vidya Onlus (Syracuse).
A session of Yoga Vidya method
involves postures (asana, in Sanskrit),
breathing exercises (pranayama, in
Sanskrit), some concentration exercises
(meditation) and relaxation.19
According to the pathology of schizo-
phrenia, there were selected some specific
postures, breathing exercises and medita-
tion. 
Particularly, the Yoga Vidya classes for
schizophrenic patients concerned postures
as: 
1. Sun Salutation, (Surya namaskara in
Sanskrit, it is a series of 12 postures per-
formed in a single graceful flow where
the movement is coordinated with the
breath); 
2. Single Leg Lift, (Eka-pada-
utthanasanain Sanskrit); 
3. Leg Lock Pose (Apanamuktasana in
Sanskrit); 
4. Universal Spinal Twist (Udara-karsa-
nasana, in Sanskrit); 
5. Bridge Posture (Setu-Bandha-asana, in
Sanskrit); 
6. Back Stretching pose
(Pascimottanasana, in Sanskrit); 
7. Tree Posture (Vrksasana, in Sanskrit).
Regarding the breathing exercise
(pranayama), there have been selected five
breathing exercises: 
1. Diaphragmatic Breathing;
2. Complete Breathing; 
3. Anuloma-Viloma, (it is a breathing exer-
cise where the breath is guided with a
specific rhythm, counting from 1 to 10
during the inhalation and from 10 to 1
during the exhalation);
4. Kapalabhati, (it is a breathing exercise
that involves a forceful exhalation
before an automatic natural inhalation.
After a given series of exhalations and
inhalations, the breath is hold as long as
possible);
5. Nadisuddhi, (it is an alternate nostril
breathing exercise where the rhythm of
inhalation, retention and exhalation
uses a given ratio that is 1:4:2 – one
beat inhale, four beats retention, two
beats exhale. As for example, counting
from 1 to 3 (inhale), 1-12 (retention), 1-
6 (exhale).
Moreover, postures (asana) work on the
various systems of the body, so that each
posture involves a given breathing pattern,
stimulating and balancing all the systems of
the body, including the endocrine, circulato-
ry, respiratory and digestive ones. The
breathing exercises (pranayama) are
focused on the respiratory system, regulat-
ing the deep oxygen exchange.
Accordingly, the first result is a more
relaxed and clear brain. At the same time,
the vital energy of the practitioners is
recharged. Secondly, the practitioners gain a
physical, physiological, and emotional
steadiness.19
Results
The IBM software SPSS 24 was used
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for statistical analysis, with the objective of
assessing over time variations of the results
obtained through the administration of the
rating scales used at baseline (T0) and after
3 months (T1). To ensure the similarity in
the characteristics of the two samples in sta-
tistical terms at baseline, these were com-
pared using analysis of variance and a t-test
for independent samples; no statistically
significant difference between the two sam-
ples was found with the alpha level of sig-
nificance defined at 5% (P<0.05).
An analysis of variance (ANOVA)
mixed with repeated measures was per-
formed (with the two types of treatment
applied as factors between subjects and the
two temporal observations (T0 and T1) as
factors within subject, and also by analyzing
the “interaction time X treatment”) in order
to assess the impact of the yoga interven-
tion. All the patients completed the study.
The 30 participants enrolled in this
study were divided into two groups of the
same size, equal to 15.All participants
equally divided for gender, in fact 15 were
male and 15 females (Table 1), with a mean
age of 37.1 years 36.9 for the experimental
group and 37.2 for the control
group (Table 2).
Analyzing the entire sample data (inter-
vention, non-intervention) at baseline (T0),
we observed: blood cortisol levels were
343.3 nanomoles (SD 107.15); blood
Dehydroepiandrosterone (DHEA) levels
were 1.95 nanomoles (SD 0.55); the overall
score for the EuroQol VAS results were
41.1 (SD 29.3); The PANSS total score was
120.4 (SD 40.5); The MINI-ICF-app total
score was 32.5 (SD 9.7); the PSS total score
was 19.9 (SD 7.1) 
Table 3 shows a comparison of the
EuroQol VAS, PSS, Total  PANSS and
Mini-ICF-APP scores and blood cortisol
levels recorded after three months (T1)
between the two groups.
The median PSS score before the inter-
vention in the intervention group was 21.5
nanomoles, and decreased to 18.1 after the
intervention (P<0.007). 
The statistical analysis did not reveal a
significant difference between the stress
perception assessed by PSS in the two
groups either before or after the interven-
tion.
For other psychological measures we
observed a significant difference between
yoga group vs control group in Quality of
Life as assessed by EuroQol VAS
(P<0.001). 
Moreover, in the experimental group a
significant decrease in the PANSS score
was also observed, this could represent a
sign of potential psychopathological
improvement. A not significant improve-
ment was reported in the control group.
Even more encouraging is the decrease in
the Mini-ICF-APP scores (more significant
for the yoga group).
Table 4 shows a comparison of the
blood cortisol and blood DHEA levels
recorded after three months (T1) between
the two groups.
The median blood cortisol level before
the intervention in the group that received
yoga was 417.7 mg/dL, and decreased to
341.5 after the yoga intervention (P<0.006).
The median blood cortisol level before the
intervention in the group that not received
yoga was 268.8 mg/dL, and increased to
319.8 after the intervention (P<0.001). The
statistical analysis reveals a significant dif-
ference between the cortisol level in the two
groups either before and after the interven-
tion.
The median blood DHEA level before
the intervention in the group that received
yoga was 2.4 ug/mL, and was decreased to
1.7 after the intervention (P<0.001). The
median blood DHEA level before the inter-
vention in the group that not received yoga
was 1.5 ug/mL, and was slowly decreased
to 1.2 after the intervention (P<0.031). The
statistical analysis reveals a significant dif-
ference between the DHEA level only in the
yoga group before and after the interven-
tion. Therefore, it’s possible sustain that it is
likely that the yoga activity determined a
positive effect on physical stress levels as
objectively measured principally by cortisol
blood levels.
Discussion and Conclusions
In the present study, yoga has been inte-
grated with the standard treatment. The
research investigated how the integration
between yoga and standard care, led to
improvements in quality of life, stress bio-
logical parameter and psychopathological
and adaptive functioning. The sample con-
sisted of residential patients with a diagno-
sis of schizophrenia. The place where the
treatment was administered (Villa Chiara) is
                             Article
Table 1. Demographic characteristic of the
two groups. Composition of the sample:
sex.
Group              Males     Females    Total
Intervention              8                    7                 15
Control                          7                     8                  15
Table 2. Demographic characteristic of the two groups. Composition of the sample: age.
Group                               Mean                     SD                     Min                        Max
Intervention                                 36.9                              9.1                              21                                   58
Control                                              37.2                                9.5                                22                                      59
SD, standard deviation.
Table 3. Comparison between the two groups.
Group                 Mean  (active)          SD (active)        Mean (control)        SD (control)
EuroQol VAS                        55.3                                   21.3                                 34.2                                   35.4
PSS                                            18.1                                       9.5                                    18.9                                      9,3
Total PANSS                         95.5                                   35.2                               101.1                                  28.2
Mini-ICF-APP                          27.6                                       9.1                                    30.2                                      8.7
SD, standard deviation.
Table 4. Comparison of the blood cortisol and blood DHEA levels recorded after three
months (T1) between the two groups.
                                                        Group                               Mean                          SD
Cortisol Baseline                                     Yoga group                                     417.7                                 112.2
Cortisol Retest                                             Yoga group                                        341.5                                    115.7
Cortisol Baseline                                  No Yoga group                                  268.8                                 102.1
Cortisol Retest                                          No Yoga group                                     319.8                                    109.8
DHEA Baseline                                         Yoga group                                       2.4                                     9.3
DHEA Retest                                                 Yoga group                                          1.7                                        0.9
DHEA Baseline                                      No Yoga group                                    1.5                                     0.8
DHEA Retest                                              No Yoga group                                       1.2                                        0.6
SD, standard deviation.
[page 24]                                                                [Mental Illness 2019; 11:8003]
No
n-c
om
me
rci
al 
us
e o
nly
                                             [Mental Illness 2019; 11:8003]                                                               [page 25]
conceived to harmonize therapeutic-reha-
bilitation with socio-rehabilitative prac-
tices, which allows patients to regain their
interpersonal relationships by supporting
the achievement of the main clinical goals.
Particular yoga program for patients
with mental illness is based on the Yoga
Vidya model. Almost all packages include
some pranayama/breathing and asanas pat-
terns but not meditative practices, because
meditation has been shown to worsen/pro-
voke psychosis in patients with mental ill-
ness.20 A study by researchers at the Swami
Vivekananda Yoga Anusandhana
Samsthana (SVYASA) was likely the first
to scientifically test such a program in
chronically ill patients. In this study, institu-
tionalized patients with mental illness,
specifically with schizophrenia, were able
to learn the yoga under supervision and the
yogasana program produced some cogni-
tive benefits in schizophrenia patients with-
out causing disturbing side effects.21
Our research goal was to detect which
result a yoga approach might have on the
biopsychological, psychopathological and
adaptive functioning, together with the stan-
dard treatment, employed in the treatment
of residential patients afflicted by schizo-
phrenia.
The whole sample was randomly divid-
ed in two groups of equal size. The experi-
mental group (n:15) participated to a treat-
ment organized over 12 weeks, with 1
weekly sessions of one hour and half,
devoted to the completion of the yoga exer-
cises, for a total of 18 hours. The control
group (n:15) undertook the usual generic
treatment. At T1, patients were again evalu-
ated using the same tests administered at
baseline. The addition of yoga therapy to
the standard intervention resulted in a sig-
nificant well-being improvement.
Alongside the improvement in neuro-cogni-
tive functioning obtained in the experimen-
tal group, an improvement in the psy-
chopathological (reduction in total PANSS
score) and adaptive functioning (reduction
in Mini-ICF-APP score) was simultaneous-
ly recorded.
The reduction of Mini-ICF-APP score
is of particular importance remembering the
residential context of patients. 
Further researches on this field may be
necessary in order to deepen and validate
the results produced by the use of yoga
other standard rehabilitation treatments.
This can lead researchers to derive the best
rehabilitative approaches supporting a
wider well-being and a generalization of the
clinical outcomes on patients’ daily life.
Because of its design, there are a num-
ber of limitations that must be considered
when interpreting the findings of this study
(e.g. the small sample size). Some charac-
teristics of the sample limit generalization
of the findings; all participants were inpa-
tients. Last but not least, the findings report-
ed from urban Sicilian residents in this
study may not be valid for other population
samples. Nonetheless, our study indicated
that yoga is a safe and inexpensive strategy
that can be quite effective for people with
schizophrenia. This can represent a good
starting point for new studies to improve
yoga intervention for this special popula-
tion. However, large and carefully conduct-
ed RCTs will be required before a definite
answer about the efficacy and safety of
these approach be formulated.
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